362 related articles for article (PubMed ID: 26268440)
1. Direct bioresorbable vascular scaffold implantation: Feasibility and midterm results.
Suárez de Lezo J; Martín P; Mazuelos F; Nóvoa J; Ojeda S; Pan M; Segura J; Hernández E; Romero M; Melián F; Medina A; Suárez de Lezo J
Catheter Cardiovasc Interv; 2016 Apr; 87(5):E173-82. PubMed ID: 26268440
[TBL] [Abstract][Full Text] [Related]
2. Bioresorbable vascular scaffolds for small vessels coronary disease: The BVS-save registry.
Latini RA; Granata F; Ielasi A; Varricchio A; Moscarella E; Tespili M; Cortese B
Catheter Cardiovasc Interv; 2016 Sep; 88(3):380-7. PubMed ID: 27038332
[TBL] [Abstract][Full Text] [Related]
3. Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry.
Naganuma T; Colombo A; Lesiak M; Capodanno D; Gori T; Nef H; Caramanno G; Naber C; Di Mario C; Ruparelia N; Capranzano P; Wiebe J; Araszkiewicz A; Geraci S; Kawamoto H; Pyxaras S; Mattesini A; Münzel T; Tamburino C; Latib A
Catheter Cardiovasc Interv; 2017 Jan; 89(1):47-56. PubMed ID: 27414021
[TBL] [Abstract][Full Text] [Related]
4. Routine use of optical coherence tomography in bioresorbable vascular scaffold implantation: insights on technique optimization and long-term outcomes.
Abdelaziz HK; Abuomara HZ; Ali MH; Eichhofer J; Patel B; Saad M
Coron Artery Dis; 2019 Jun; 30(4):263-269. PubMed ID: 30883433
[TBL] [Abstract][Full Text] [Related]
5. Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold versus everolimus-eluting stent for coronary bifurcation lesions.
Naganuma T; Kawamoto H; Panoulas VF; Latib A; Tanaka A; Mitomo S; Ruparelia N; Jabbour RJ; Chieffo A; Carlino M; Montorfano M; Colombo A
Int J Cardiol; 2017 Nov; 246():26-31. PubMed ID: 28867010
[TBL] [Abstract][Full Text] [Related]
6. Is high pressure postdilation safe in bioresorbable vascular scaffolds? Optical coherence tomography observations after noncompliant balloons inflated at more than 24 atmospheres.
Fabris E; Caiazzo G; Kilic ID; Serdoz R; Secco GG; Sinagra G; Lee R; Foin N; Di Mario C
Catheter Cardiovasc Interv; 2016 Apr; 87(5):839-46. PubMed ID: 26370357
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes following target lesion revascularization for bioresorbable scaffold failure.
Tanaka A; Ruparelia N; Kawamoto H; Sticchi A; Figini F; Carlino M; Chieffo A; Montorfano M; Latib A; Colombo A
Catheter Cardiovasc Interv; 2016 Apr; 87(5):832-6. PubMed ID: 26331577
[TBL] [Abstract][Full Text] [Related]
8. Comparison of early clinical outcomes between ABSORB bioresorbable vascular scaffold and everolimus-eluting stent implantation in a real-world population.
Costopoulos C; Latib A; Naganuma T; Miyazaki T; Sato K; Figini F; Sticchi A; Carlino M; Chieffo A; Montorfano M; Colombo A
Catheter Cardiovasc Interv; 2015 Jan; 85(1):E10-5. PubMed ID: 24909303
[TBL] [Abstract][Full Text] [Related]
9. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
[TBL] [Abstract][Full Text] [Related]
10. The duration of balloon inflation affects the luminal diameter of coronary segments after bioresorbable vascular scaffolds deployment.
Sorrentino S; De Rosa S; Ambrosio G; Mongiardo A; Spaccarotella C; Polimeni A; Sabatino J; Torella D; Caiazzo G; Indolfi C
BMC Cardiovasc Disord; 2015 Dec; 15():169. PubMed ID: 26654975
[TBL] [Abstract][Full Text] [Related]
11. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.
Onuma Y; Dudek D; Thuesen L; Webster M; Nieman K; Garcia-Garcia HM; Ormiston JA; Serruys PW
JACC Cardiovasc Interv; 2013 Oct; 6(10):999-1009. PubMed ID: 24156961
[TBL] [Abstract][Full Text] [Related]
12. Clinical, Angiographic, Functional, and Imaging Outcomes 12 Months After Implantation of Drug-Eluting Bioresorbable Vascular Scaffolds in Acute Coronary Syndromes.
Gori T; Schulz E; Hink U; Kress M; Weiers N; Weissner M; Jabs A; Wenzel P; Capodanno D; Münzel T
JACC Cardiovasc Interv; 2015 May; 8(6):770-777. PubMed ID: 25999097
[TBL] [Abstract][Full Text] [Related]
13. Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data.
Bourantas CV; Serruys PW; Nakatani S; Zhang YJ; Farooq V; Diletti R; Ligthart J; Sheehy A; van Geuns RJ; McClean D; Chevalier B; Windecker S; Koolen J; Ormiston J; Whitbourn R; Rapoza R; Veldhof S; Onuma Y; Garcia-Garcia HM
EuroIntervention; 2015 Nov; 11(7):746-56. PubMed ID: 25308301
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.
Moscarella E; Ielasi A; Granata F; Coscarelli S; Stabile E; Latib A; Cortese B; Tespili M; Tanaka A; Capozzolo C; Caliendo L; Colombo A; Varricchio A
Circ Cardiovasc Interv; 2016 Apr; 9(4):e003148. PubMed ID: 27059683
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Accuracy of Coronary CT Angiography for the Evaluation of Bioresorbable Vascular Scaffolds.
Collet C; Chevalier B; Cequier A; Fajadet J; Dominici M; Helqvist S; Van Boven AJ; Dudek D; McClean D; Almeida M; Piek JJ; Tenekecioglu E; Bartorelli A; Windecker S; Serruys PW; Onuma Y
JACC Cardiovasc Imaging; 2018 May; 11(5):722-732. PubMed ID: 28734923
[TBL] [Abstract][Full Text] [Related]
16. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance.
Mattesini A; Secco GG; Dall'Ara G; Ghione M; Rama-Merchan JC; Lupi A; Viceconte N; Lindsay AC; De Silva R; Foin N; Naganuma T; Valente S; Colombo A; Di Mario C
JACC Cardiovasc Interv; 2014 Jul; 7(7):741-50. PubMed ID: 25060016
[TBL] [Abstract][Full Text] [Related]
17. Bioresorbable Vascular Scaffolds for the Treatment of Chronic Total Occlusions: An International Multicenter Registry.
Mitomo S; Naganuma T; Fujino Y; Kawamoto H; Basavarajaiah S; Pitt M; Yin WH; Tresukosol D; Colombo A; Nakamura S
Circ Cardiovasc Interv; 2017 Jan; 10(1):. PubMed ID: 28069611
[TBL] [Abstract][Full Text] [Related]
18. Procedural and one-year clinical outcomes of bioresorbable vascular scaffolds for the treatment of chronic total occlusions: a single-centre experience.
Özel E; Taştan A; Öztürk A; Özcan EE; Kilicaslan B; Özdogan Ö
Cardiovasc J Afr; 2016 Nov/Dec 23; 27(6):345-349. PubMed ID: 27078224
[TBL] [Abstract][Full Text] [Related]
19. Scaffold Thrombosis After Percutaneous Coronary Intervention With ABSORB Bioresorbable Vascular Scaffold: A Systematic Review and Meta-Analysis.
Lipinski MJ; Escarcega RO; Baker NC; Benn HA; Gaglia MA; Torguson R; Waksman R
JACC Cardiovasc Interv; 2016 Jan; 9(1):12-24. PubMed ID: 26762906
[TBL] [Abstract][Full Text] [Related]
20. Clinical and angiographic outcome of a single center, real world population treated with a dedicated technique of implantation for bioresorbable vascular scaffolds. The FAtebenefratelli Bioresorbable Vascular Scaffold (FABS) registry.
Cortese B; di Palma G; Cerrato E; Latini RA; Elwany M; Orrego PS; Seregni RG
J Interv Cardiol; 2017 Oct; 30(5):427-432. PubMed ID: 28853189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
